| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0003 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.00032 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00016 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 9.3e-05 | 1 |